Literature DB >> 28661738

Nonmaleficence, Nondisclosure, and Nocebo: Response to Open Peer Commentaries.

John T Fortunato1, Jason Adam Wasserman1, Daniel Londyn Menkes1.   

Abstract

Mesh：

Year:  2017        PMID： 28661738     DOI： 10.1080/15265161.2017.1334841

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  1 in total

1.  One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology.

Authors:  Wieland D Müskens; Sanne A A Rongen-van Dartel; Steven Teerenstra; Eddy M M Adang; Piet L C M van Riel
Journal:  Rheumatol Adv Pract       Date:  2020-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.